Fig. 10

Effect of delayed nasal MSC administration on cisplatin-induced cognitive deficits. Male (A and C) and female (B and D) mice were treated with cisplatin followed by MSC and cognitive performance was assessed by PBT (A and B) and NOPRT (C and D) as depicted in Fig. 9A. Results are expressed as mean ± SEM; n = 8 mice/group (4 males, 4 females); * p < 0.05; ****p < 0.0001.